Ivermectin.com
📰 Research & Commentary

Health Freedom Articles

Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.

All Albendazole Azithromycin Doxycycline Fenbendazole GermProof Hydroxychloroquine Ivermectin Mebendazole Medical Freedom Parasitology Pharmacology Praziquantel
Fenbendazole Articles
15 articles · Updated daily
🔬 Fenbendazole

Fenbendazole Safety: Side Effects, Risks, and What Data Shows

Fenbendazole is a veterinary dewormer, not an approved human drug. Here is what toxicology, veterinary data, and human case reports actually show about its risks.

fenbendazolesafety
✍️ Dr. James Harmon, Research Correspondent · 2026-08-05 Read →
🔬 Fenbendazole

Fenbendazole vs Mebendazole: Mechanism, Uses, and Key Differences

Fenbendazole and mebendazole share a drug class and mechanism, but one is a veterinary medicine and the other a licensed human drug—an important distinction.

fenbendazolecomparison
✍️ Dr. James Harmon, Research Correspondent · 2026-08-03 Read →
🔬 Fenbendazole

Fenbendazole for Intestinal Worms: Evidence, Dosing, Expectations

Fenbendazole is a well-studied veterinary dewormer with strong animal evidence but no FDA approval for human use.

fenbendazoleconditionintestinal worms
✍️ Dr. James Harmon, Research Correspondent · 2026-08-02 Read →
🔬 Fenbendazole

Fenbendazole and Tubulin: The Science Behind the Headlines

Fenbendazole belongs to a drug class that disables a cell's internal scaffolding. Here is what the tubulin research actually shows—and does not show.

fenbendazolemechanismscience
✍️ Dr. James Harmon, Research Correspondent · 2026-07-28 Read →
🔬 Fenbendazole

Fenbendazole and Cancer: What the Research Actually Shows

A sober look at fenbendazole's laboratory and animal cancer studies — what has been shown, what hasn't, and what remains unknown in humans.

fenbendazolecancerresearch
✍️ Dr. James Harmon, Research Correspondent · 2026-07-28 Read →
🔬 Fenbendazole

Joe Tippens, Fenbendazole, and the Cancer Story Big Pharma Won't Tell You

In 2016, Joe Tippens was given three months to live with small-cell lung cancer. His recovery with fenbendazole sparked a global research movement.

fenbendazolecancerresearch
✍️ Dr. James Harmon, Research Correspondent · 2026-03-09 Read →